156 Episodo

  1. Inhaled budesonide in the treatment of early COVID-19

    Publicado: 15/4/2021

  2. Tocilizumab and COVID-19

    Publicado: 5/3/2021

  3. Interferon treatment and COVID-19

    Publicado: 6/2/2021

  4. Evaluating deterioration in patients with acute COVID-19

    Publicado: 12/1/2021

  5. Treatment options in patients with systemic sclerosis-associated interstitial lung disease

    Publicado: 5/1/2021

  6. COVID-19 and severe influenza

    Publicado: 18/12/2020

  7. The second wave and homeless populations

    Publicado: 11/11/2020

  8. Corticosteroids, COPD, asthma and COVID-19

    Publicado: 25/9/2020

  9. Novel strategies to drive down the global burden of asthma

    Publicado: 8/9/2020

  10. The pathology of suspected EVALI

    Publicado: 5/8/2020

  11. Wheezing illness and RSV-LRTI

    Publicado: 17/7/2020

  12. Antibiotic use in infancy and asthma incidence

    Publicado: 16/3/2020

  13. Guidance on the development of prediction models for critical care

    Publicado: 12/3/2020

  14. Potential exacerbations in patients with COPD

    Publicado: 3/3/2020

  15. CPAP and mild obstructive sleep apnea

    Publicado: 28/11/2019

  16. An algorithm for EVALI

    Publicado: 8/11/2019

  17. Lung transplants from Hepatitis C viremic donors

    Publicado: 5/10/2019

  18. Looking to the future of cystic fibrosis care

    Publicado: 29/9/2019

  19. Pamrevlumab and idiopathic pulmonary fibrosis

    Publicado: 27/9/2019

  20. Nicotine patches, e-cigarettes, and smoking cessation

    Publicado: 10/9/2019

3 / 8

Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.

Visit the podcast's native language site